Locally advanced prostate cancer—biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy-Reference-Cited by-同舟云学术

Locally advanced prostate cancer—biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy

Published:2007 Issue:5 Volume:109 Page:858-867
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bruchovsky Nicholas,Klotz Laurence,Crook Juanita,Goldenberg S. Larry

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference13 articles.

1. Intermittent Androgen Deprivation Therapy for Prostate Cancer

2. Should Intermittent Androgen Deprivation Be Used in Routine Clinical Practice?

3. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen

4. Prostate cancer: molecular biology of early progression to androgen independence.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Liouville optimal control framework in prostate cancer;Applied Mathematical Modelling;2024-10

2. Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics;Cancer Research;2023-05-19

3. A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapy;Journal of Pharmacokinetics and Pharmacodynamics;2021-02-04

4. The history of intermittent androgen- deprivation therapy — A Canadian story;Canadian Urological Association Journal;2020-05-18

5. Population pharmacokinetic–pharmacodynamic modelling of the relationship between testosterone and prostate specific antigen in patients with prostate cancer during treatment with leuprorelin;British Journal of Clinical Pharmacology;2019-04-03